See All Slides - tctmd.com

Slides

Presentation TCT 2013

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Presenter: Subhash Banerjee, Rick Weideman, Bertis Little, Mark Weideman, Jennifer Gunter, Kevin Kelly, Emmanouil Brilakis

January 31, 2013

Presentation TCT 2013

Coronary artery disease in patients with reduced left ventricular systolic function treated with medicine, surgery, or percutaneous coronary intervention: a retrospective review...

Presenter: Matthew LaBarbera, Peter Hui, Richard Shaw

January 31, 2013

Presentation TCT 2013

Real-World Comparison of Clinical Outcomes of Patients who Received New Generation Platinum Chromium Everolimus-Eluting Stent versus Cobalt Chromium Everolimus-Eluting Stent

Presenter: Ruogu Li, Adrian Low, Chi Hang Lee, Mark Chan, Swee Guan Teo, Koo Hui Chan, Mark Richards Arthur, Huay Cheem Tan

January 31, 2013

Presentation TCT 2013

Comparison of safety and efficacy between transradial intervention (TRI) and transfemoral intervention (TFI) in acute myocardial infarction; result from KORMI registry data

Presenter: Byung-Hyun Joe

January 31, 2013

Presentation TCT 2013

Validation of Transapical Access Accuracy of Computed Tomographic Angiography-Fluoroscopy Fusion Guided Structural Heart Disease Interventions

Presenter: Bryce Einhorn, Sonnit Sharma, Francisco Cuesta, Chad Kliger, Bart Carelsen, Vladimir Jelnin, Howard Cohen, Greg Fontana, Carlos Ruiz

January 31, 2013

Presentation TCT 2013

The Impact of Vascular Access for In-Hospital Major Bleeding in Acute Coronary Syndrome Patients with Moderate- to Very High-Bleeding Risk

Presenter: Keun-Ho Park, Myung Ho Jeong, Youngkeun Ahn, Sang Cheol Cho, Jong Hyun Yoo, Hee-Yeol Kim, Keum-Soo Park, Seung-Woon Rha

January 31, 2013

Presentation TCT 2013

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Presenter: Aris Moschovitis, Giulio Stefanini, Michael Magro, Lorenz R?ber, Bindu Kalesan, Masanori Taniwaki, Joost Daemen, Peter Wenaweser, Ron Van Domburg, Bernhard Meier, Peter Juni, Patrick Serruys, Stephan Windecker

January 31, 2013

Presentation TCT 2013

Long-term Outcomes After Transcatheter Closure of Patent Foramen Ovale

Presenter: Sammy Elmariah, Ignacio Inglessis, Pablo Rengifo, Ronan Margey, Suzanne Baron, Caitlin O'Callaghan, Ignacio Cruz-Gonz?lez, Zareh Demirjian, Ferdinando Buonanno, MingMing Ning, Scott Silverman, Eugene Pomerantsev, Robert Schainfeld, G. Dec, Igor Palacios

January 31, 2013

Presentation TCT 2013

Familial Hypercholesterolemic Swine In-Stent Restenosis Model, But Not Contemporaneous Injury+Treatment Model, Predicts Efficacy of Drug Coated Balloon in Peripheral Arteries

Presenter: Maxwell Afari, Armando Tellez, Yanping Cheng, Seung-Jin Oh, Piotr Buszman, Krzysztof Milewski, Jong Shiuan Yeh, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Is the rate of femoral access site complications increased in the hands of 'radialists'?

Presenter: Stefano Rigattieri, Cristian Di Russo, Maria Cera, Silvio Fedele, Giuseppe Ferraiuolo, Giuliano Altamura, Francesco Pugliese, Paolo Loschiavo

January 31, 2013

Advertisement

Slides

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Coronary artery disease in patients with reduced left ventricular systolic function treated with medicine, surgery, or percutaneous coronary intervention: a retrospective review...

Real-World Comparison of Clinical Outcomes of Patients who Received New Generation Platinum Chromium Everolimus-Eluting Stent versus Cobalt Chromium Everolimus-Eluting Stent

Comparison of safety and efficacy between transradial intervention (TRI) and transfemoral intervention (TFI) in acute myocardial infarction; result from KORMI registry data

Validation of Transapical Access Accuracy of Computed Tomographic Angiography-Fluoroscopy Fusion Guided Structural Heart Disease Interventions

The Impact of Vascular Access for In-Hospital Major Bleeding in Acute Coronary Syndrome Patients with Moderate- to Very High-Bleeding Risk

The Impact of Left Main Disease on Long-term Clinical Outcomes Among Patients Treated With The Unrestricted Use of Everolimus-Eluting, Sirolimus-Eluting, and Paclitaxel-Eluting...

Long-term Outcomes After Transcatheter Closure of Patent Foramen Ovale

Familial Hypercholesterolemic Swine In-Stent Restenosis Model, But Not Contemporaneous Injury+Treatment Model, Predicts Efficacy of Drug Coated Balloon in Peripheral Arteries

Is the rate of femoral access site complications increased in the hands of 'radialists'?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content